Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

Share Price is delayed by 15 minutes
Get Live Data
147.50    -1.50 (-1.01%)
Bid:
145.00
Ask:
150.00
Spread: 5.00 (3.448%)
Market Cap: £45.56m
GATC Live PriceLast checked at - London Stock Exchange

Intraday Gattaca Share Chart

Additional Listing

30 Jul 2008 17:22

RNS Number : 2621A
Matchtech Group PLC
30 July 2008
 

MATCHTECH GROUP PLC

30 July 2008

EXERCISE OF OPTIONS

Application has been made for the admission to trading on AIM of 21,206 new ordinary shares of 1p each in the Company ("Shares"), pursuant to the exercise of options under the Company's EMI Share Option Scheme.

The Shares will rank pari passu in all respects with the Company's existing issued ordinary shares, and admission ("Admission") is expected to occur on 4 August 2008.

TOTAL VOTING RIGHTS

Following Admission, the Company's enlarged issued share capital will comprise 23,229,943 ordinary shares with voting rights. The Company does not hold any shares in treasury. This figure of 23,229,943 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISZGGFNVGGGRZM
Date   Source Headline
15th Feb 20237:00 amRNSTrading Statement
10th Feb 20239:05 amRNSSecond Price Monitoring Extn
10th Feb 20239:00 amRNSPrice Monitoring Extension
14th Dec 20223:02 pmRNSIssue of Ordinary Shares & Total Voting Rights
6th Dec 20221:55 pmRNSDirector/PDMR Shareholding
6th Dec 202212:55 pmRNSResult of AGM
3rd Nov 20227:00 amRNSPreliminary Results for the year ended 31 July 22
3rd Oct 202211:03 amRNSBlock Listing Six Monthly Return
29th Sep 20224:54 pmRNSEBT Share Purchase Programme
17th Aug 20227:00 amRNSTrading Update
8th Jul 202211:05 amRNSSecond Price Monitoring Extn
8th Jul 202211:00 amRNSPrice Monitoring Extension
8th Jul 20229:06 amRNSSecond Price Monitoring Extn
8th Jul 20229:00 amRNSPrice Monitoring Extension
6th May 202211:55 amRNSDirector/PDMR Shareholding
4th Apr 20224:20 pmRNSConfirmation of Director Appointment
1st Apr 20229:35 amRNSBlock listing six monthly return
31st Mar 20227:00 amRNSInterim Results
15th Mar 20227:00 amRNSBoard Succession
18th Jan 20229:05 amRNSSecond Price Monitoring Extn
18th Jan 20229:00 amRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSTrading Update
16th Dec 20211:40 pmRNSDirector/PDMR Shareholding
8th Dec 20214:14 pmRNSResult of AGM
8th Dec 20214:10 pmRNSDirectorate Change
2nd Dec 202111:06 amRNSSecond Price Monitoring Extn
2nd Dec 202111:00 amRNSPrice Monitoring Extension
4th Nov 20219:05 amRNSSecond Price Monitoring Extn
4th Nov 20219:00 amRNSPrice Monitoring Extension
4th Nov 20217:00 amRNSPreliminary Results for the year ended 31 July 21
1st Oct 20219:09 amRNSBlock Listing Six Monthly Return
20th Sep 202111:00 amRNSPrice Monitoring Extension
17th Aug 20217:00 amRNSTrading Update
13th Jul 202110:50 amRNSDirector/PDMR Shareholding
17th Jun 202112:01 pmRNSDirector/PDMR Shareholding
10th Jun 20214:20 pmRNSDirector/PDMR Shareholding
8th Jun 202111:00 amRNSPrice Monitoring Extension
26th May 20214:40 pmRNSSecond Price Monitoring Extn
26th May 20214:35 pmRNSPrice Monitoring Extension
21st May 20215:28 pmRNSDirector/PDMR Shareholding
21st May 202111:58 amRNSHolding(s) in Company
21st May 20217:00 amRNSTrading Update - Improved Outlook
14th May 202111:37 amRNSHolding(s) in Company
13th May 20211:24 pmRNSHolding(s) in Company
11th May 202111:34 amRNSHolding(s) in Company
23rd Apr 20212:53 pmRNSHolding(s) in Company
1st Apr 20219:29 amRNSBlock Listing Six Monthly Return
31st Mar 20217:00 amRNSInterim Results for the six months ended 31 Jan 21
17th Feb 20217:00 amRNSTrading Update
8th Dec 20201:05 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.